Takeda Pharmaceutical Co Stock Alpha and Beta Analysis
| TAK Stock | USD 15.01 0.02 0.13% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Takeda Pharmaceutical Co. It also helps investors analyze the systematic and unsystematic risks associated with investing in Takeda Pharmaceutical over a specified time horizon. Remember, high Takeda Pharmaceutical's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Takeda Pharmaceutical's market risk premium analysis include:
Beta 0.26 | Alpha 0.16 | Risk 1.19 | Sharpe Ratio 0.18 | Expected Return 0.21 |
Takeda Pharmaceutical Quarterly Cash And Equivalents |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Takeda |
Takeda Pharmaceutical Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Takeda Pharmaceutical market risk premium is the additional return an investor will receive from holding Takeda Pharmaceutical long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Takeda Pharmaceutical. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Takeda Pharmaceutical's performance over market.| α | 0.16 | β | 0.26 |
Takeda Pharmaceutical expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Takeda Pharmaceutical's Buy-and-hold return. Our buy-and-hold chart shows how Takeda Pharmaceutical performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Takeda Pharmaceutical Market Price Analysis
Market price analysis indicators help investors to evaluate how Takeda Pharmaceutical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Takeda Pharmaceutical shares will generate the highest return on investment. By understating and applying Takeda Pharmaceutical stock market price indicators, traders can identify Takeda Pharmaceutical position entry and exit signals to maximize returns.
Takeda Pharmaceutical Return and Market Media
The median price of Takeda Pharmaceutical for the period between Sun, Dec 15, 2024 and Sat, Mar 15, 2025 is 13.39 with a coefficient of variation of 4.73. The daily time series for the period is distributed with a sample standard deviation of 0.65, arithmetic mean of 13.63, and mean deviation of 0.51. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Takeda Delivers Strong Third-Quarter FY2024 Results Raises Full Year Outlook, Forecasting ... | 01/30/2025 |
2 | SYM FINANCIAL Corp Invests 140,000 in Takeda Pharmaceutical Company Limited | 02/03/2025 |
3 | 2025 Research Peptides and Heparin Market Forecasted to Reach USD 20.19 Billion by 2030, Growing at a CAGR of 8.32 percent - Growth Driven by Advancements in Me... | 02/25/2025 |
4 | Is Takeda Pharmaceutical Company Limited the Best Low Price Pharma Stock to Invest In Right Now | 02/27/2025 |
5 | Takeda iP HoldingsLtd Is Increasing Its Dividend To 23.00 | 03/03/2025 |
6 | Takeda Pharmaceutical ADR Trying To Close In On Key Technical Measure | 03/04/2025 |
7 | Nimbus swaps CEOs and turns to new leader for next chapter | 03/07/2025 |
8 | Beam Base Editors Early Data in Rare Liver Disease Tee Up 500M Stock Sale in Tough Market | 03/10/2025 |
9 | AC Immune Reports Full Year 2024 Financial Results and Provides a Corporate Update | 03/13/2025 |
About Takeda Pharmaceutical Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Takeda or other stocks. Alpha measures the amount that position in Takeda Pharmaceutical has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2022 | 2024 | 2025 (projected) | Dividend Yield | 0.0414 | 0.0397 | 0.0417 | Price To Sales Ratio | 1.68 | 1.75 | 1.67 |
Takeda Pharmaceutical Upcoming Company Events
As portrayed in its financial statements, the presentation of Takeda Pharmaceutical's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Takeda Pharmaceutical's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Takeda Pharmaceutical's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Takeda Pharmaceutical. Please utilize our Beneish M Score to check the likelihood of Takeda Pharmaceutical's management manipulating its earnings.
| 1st of February 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 9th of May 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of March 2023 Last Financial Announcement | View |
Build Portfolio with Takeda Pharmaceutical
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Takeda Pharmaceutical Backtesting, Takeda Pharmaceutical Valuation, Takeda Pharmaceutical Correlation, Takeda Pharmaceutical Hype Analysis, Takeda Pharmaceutical Volatility, Takeda Pharmaceutical History and analyze Takeda Pharmaceutical Performance. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Takeda Pharmaceutical technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.